Skip to contentSkip to filters

We use cookies for analytics.

Reframing Addiction and Therapeutic Strategies: Neurodegenerative Signatures and Developmental Vulnerability

Yasmin Hurd

Icahn School of Medicine at Mount Sinai

Abstract

Substance use disorders, particularly those involving opioids and cannabis, are a major public health crisis with profound neurobiological and societal consequences. This lecture presents translational research that integrates human postmortem brain analyses, animal models and clinical studies to uncover the molecular mechanisms underlying addiction and related psychiatric risk.

Studies of individuals with opioid use disorder reveal overlapping transcriptional and epigenetic signatures, including disrupted oxidative phosphorylation pathways, tau-related mechanisms and PRC2-mediated gene silencing, suggesting that chronic opioid exposure engages neurodegenerative-like processes linked to drug seeking and impaired cognitive flexibility. These alterations converge with perturbations in synaptic regulatory proteins, linking addiction-related plasticity to broader neurodegenerative and neuroimmune processes in cortico-striatal circuits.

The lecture then turns to developmental vulnerability: prenatal and adolescent cannabis exposure disrupts placental immune signalling, brain development and long-term behavioural outcomes, including anxiety and other phenotypes associated with psychiatric risk. These effects converge on shared pathways involving synaptic function, oxidative stress and immune dysregulation, suggesting that early-life cannabinoid exposure may prime neurobiological systems that later intersect with addiction-related and potentially neurodegenerative processes. Finally, it discusses how these mechanistic insights can inform therapeutic development, including targeting epigenetic regulators and advancing cannabidiol as a potential intervention to reduce craving, anxiety and stress responses, toward effective, non-addictive treatments for substance use disorders.

Topics